Fig. 8

(A) Relative abundance of risk score between different histological grade and pathological stage (ANOVA test). The line and box represent median and upper and lower quartiles, respectively. (B) The levels of risk score were compared across different pathological stages in GEO (left), ICGC (middle), and Proteome cohort (right). (C) Heatmap of enriched pathways in each subtype using GSVA based on metabolism- and HCC-associated gene sets.